Head of Supply and Availability of medicines and medical devices
EMA
Dr. Dias is Head of supply and availability of medicines and devices, at EMA since October 2021 and she is responsible for the implementation of the extended mandate of EMA in the area of shortages of medicines and devices. She is Co-Chair of the HMA/EMA HMA/EMA TF AAM and she is the Chair of the Medicine Shortages SPOC Working Party.
Dr. Dias studied pharmacy in Lisbon, Portugal and obtained her PhD from the University of Cardiff, UK.
Dr. Dias joined the European Medicines Agency in 2004. She worked in the Quality Office for 10 years. In 2013 she joined the Office of the Deputy Executive Director at EMA where she was Principal Policy and Crisis Coordinating Officer. She was involved in the development of policies, best practice guidance for the anonymisation of clinical reports, and coordinated the Brexit operational preparedness activities at EMA, including the impact of Brexit on the availability of Centrally Authorised products. Dr Dias was also coordinating at EMA the activities of the HMA/EMA Task Force on the availability of authorised medicines since November 2016. During the COVID-19 pandemic Dr. Dias coordinated activities in relation to shortages due the pandemic both at EMA and with the NCAs. She was involved in the setting up the mechanisms to monitor shortages of medicines (EU Executive Steering Group on shortages) and was leading a Working Group which developed a common framework for forecasting demand data in the EU/EEA.
Disclosure information not submitted.
Wednesday, May 8, 2024
11:45 – 12:45 CEST